Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo

Journal of Clinical Investigation

Volumn 104, Issue 5, 1999, Pages

  Glushakova, Svetlana ^a   Yi, Yanjie ^b   Grivel, Jean Charles ^a   Singh, Anjali ^b   Schols, Dominique ^c   De Clercq, Erik ^c   Collman, Ronald G ^b,d   Margolis, Leonid ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; LYMPHOID TISSUE; MOLECULAR CLONING; PRIORITY JOURNAL; RECEPTOR BINDING; STRAIN DIFFERENCE; VIRUS ISOLATION; VIRUS TYPING;

EID: 0032728566     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7403     Document Type: Article

References (32)

1. Moore, J.P., Trkola, A., and Dragic, T. 1997. Coreceptors for HIV-1 entry. Curr. Opin. Immunol. 9:551-562.
2. Berger, E.A., Murphy, P.M., and Farber, M.J. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism and disease. Annu. Rev. Immunol. 17:657-700.
3. Locati, M., and Murphy, P.M. 1999. Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med. 50:425-440.
4. Dean, M., et al. 1996. Generic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 273:1856-1862.
5. Huang, Y., et al. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240-1243.
6. Liu, R., et al. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell. 86:367-377.
7. Samson, M., Labbe, O., Mollereau, C., Vassart, G., and Parmentier, M. 1996. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry. 35:3362-3367.
8. Bjorndal, A., et al. 1997. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71:7478-7487.
9. Connor, R.I., Sheridan, K.E., Ceradini, D., Choe, S., and Landau, N.R. 1997. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:621-628.
10. Simmons, G., et al. 1997. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science. 276:276-279.
11. Tersmette, M., et al. 1989. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet. 1:983-985.
12. Zhu, T., et al. 1993. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 261:1179-1181.
13. Berger, E.A., et al. 1998. A new classification for HIV-1. Nature. 391:240.
14. Glushakova, S., Baibakov, B., Zimmerberg, J., and Margolis, L. 1997. Experimental HIV infection of human lymphoid tissue: correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histoculture inoculated with laboratory strains and patient isolates of HIV type 1. AIDS Res. Hum. Retroviruses. 13:461-471.
15. Glushakova, S., Baibakov, B., Margolis, L.B., and Zimmerberg, J. 1995. Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat. Med. 1:1320-1322.
16. Penn, M.L., Grivel, J.C., Schramm, B., Goldsmith, M.A., and Margolis, L. 1999. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Proc. Natl. Acad. Sci. USA. 96:663-668.
17. Doranz, B.J., et al. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1149-1158.
18. Glushakova, S., et al. 1998. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency. Nat. Med. 4:346-349.
19. Grivel, J.C., and Margolis, L.B. 1999. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat. Med. 5:344-346.
20. Smyth, R.J., Yi, Y., Singh, A., and Collman, R.G. 1998. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate. J. Virol. 72:4478-4484.
21. Koyanagi, Y., et al. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science. 236:819-822.
22. Cheng-Mayer, C., Weiss, C., Seto, D., and Levy, J.A. 1989. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc. Natl. Acad. Sci. USA. 86:8575-8579.
23. Margolis, L.B., Glushakova, S., Grivel, J.C., and Murphy, P.M. 1998. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines. J. Clin. Invest. 101:1876-1880.
24. Schols, D., et al. 1997. Inhibition of T-tropic HIV strains by selective amagonization of the chemokine receptor CXCR4. J. Exp. Med. 186:1383-1388.
25. Donzella, G.A., et al. 1998. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 coreceptor. Nat. Med. 4:72-77.
26. Cocchi, F., et al. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 270:1811-1815.
27. Kinter, A., et al. 1998. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. Proc. Natl. Acad. Sci. USA. 95:11880-11885.
28. Gordon, C.J., et al. 1999. Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J. Virol. 73:684-694.
29. Yi, Y., Rana, S., Turner, J.D., Gaddis, N., and Collman, R.G. 1998. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J. Virol. 72:772-777.
30. Zhang, Y., and Moore, J.P. 1999. Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry? J. Virol. 73:3443-3448.
31. Shibata, R., et al. 1995. Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J. Virol. 69:4453-4462.
32. Cho, M.W., et al. 1998. Identification of determinants on a dual tropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. J. Virol. 72:2509-2515.